Pharmaceuticals and Medical Equipment in Canada

Canadian producers registered weaker turnover growth in 2017, impeded by falling drug exports to the US, which dropped by 32% in value on the back of plunging generic drug prices, increasing competition and a consolidating customer base. Lower generic prices also took a toll on producers’ profits, which fell by 12% over the year. Exports are expected to recover in 2019. Teva, Mylan, Endo, Sandoz (Novartis) and other major generic producers have started to discontinue unviable generic drugs in th...

Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals and Medical Equipment market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Product coverage: Medical and Surgical Equipment, Pharmaceuticals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Pharmaceuticals and Medical Equipment market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.